The role of corticosteroids in respiratory diseases of children

Pediatric Pulmonology

Volumn 22, Issue 1, 1996, Pages 44-57

  De Benedictis, Fernando M ^a,c   Canny, Gerard J ^b   Levison, Henry ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c POLICLINICO MONTELUCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID;

ASTHMA; BRONCHIOLITIS; BRONCHOPULMONARY ASPERGILLOMA; CHILD; CORTICOSTEROID THERAPY; CROUP; CYSTIC FIBROSIS; DRUG MECHANISM; GROWTH RETARDATION; HUMAN; OSTEOPOROSIS; PEDIATRICS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; TUBERCULOSIS;

ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; HUMANS; RESPIRATORY TRACT DISEASES;

EID: 0029759725     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199607)22:1<44::AID-PPUL7>3.0.CO;2-K     Document Type: Review

References (235)

1. Carryer HM, Koelsche GA, Prickman LE, Maytum CK, Lake CF, Williams HL. The effects of cortisone on bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollen. J Allergy. 1950; 21:282-286.
2. Morris HG. Mechanisms of glucocorticoid action in pulmonary disease. Chest 1985; 88(suppl): 133-141.
3. Taylor IK, Shaw RJ. The mechanism of action of corticosteroids in asthma. Respir Med. 1993; 87:261-277.
4. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci. 1993; 14:436-441.
5. Peers SH, Flower RJ. The role of lipocortin in corticosteroids actions. Am Rev Respir Dis. 1990; 141(suppl 2):S31-S38.
6. Sebaldt RJ, Sheller JR, Oates JA, Roberts LJ, Fitzgerald GA. Inhibition of eicosanoid synthesis by glucocorticoids. Proc Natl Acad Sci USA 1990; 87:6974-6978.
7. Manso G, Backer AJ, Taylor IK, Fuller RW. In vivo and in vitro effects of glucocorticosteroids on arachidonate acid metabolism and monocyte function in humans. Eur Respir J. 1992; 5:712-716.
8. Schleimer RP. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutical application in asthma. Am Rev Respir Dis. 1990; 141(suppl 2):S59-S69.
9. Laitinen LA, Laitinen A, Haathela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and of a beta2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992; 90:32-42.
10. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis. 1992; 145:669-674.
11. Cohan VL, Undem BJ, Fox CC, Adkinson NF, Lichtenstein LM, Schleimer RP. Dexamethasone does not inhibit the release of mediators from human lung mast cells residing in airway, intestine, or skin. Am Rev Respir Dis. 1989; 140:951-954.
12. Schwiebert LA, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP. Glucocorticosteriod inhibition of cytokine production: Relevance to antiallergic actions. J Allergy Clin Immunol. 1996; 97:143-152.
13. Boschetto P, Rogers DF, Fabbri LM, Barnes PJ. Corticosteroid inhibition of airway microvascular leakage. Am Rev Respir Dis. 1991; 143:605-609.
14. Shimura S, Sasaki T, Ikeda K, Yamauchi K, Sasaki H, Takishima T. Direct inhibitory action of glucocorticoid on glycoconjugate secretion from airway submucosal glands. Am Rev Respir Dis. 1990; 141:1044-1049.
15. Svedmyr N. Action of corticosteroids on beta-adrenergic receptors. Am Rev Respir Dis. 1990; 141(suppl 2):S31-S38.
16. Spahn JD, Leung DYM, Surs W, Harbeck RJ, Nimmagadda SAI, Szefler SJ. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. Am J Respir Crit Care Med. 1995; 151:1709-1714.
17. Booij-Noord H, Orie NGM, de Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol. 1971; 48:344-354.
18. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses and increased bronchial responsiveness to histamine. J Allergy Clin Immunol. 1987; 79:734-740.
19. Dahl R, Johansson SA. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis. 1982; 63(suppl 122):167-175.
20. Burge PS. The effects of corticosteroids on the immediate asthmatic reaction. Eur J Respir Dis. 1982; 63(suppl 122):163-166.
21. Barnes PJ. Effects of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis. 1990; 141(suppl 2):S70-S76.
22. Spector SL. Update on exercise-induced asthma. Ann Allergy. 1993; 71:571-577.
23. Henriksen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Am Rev Respir Dis. 1983; 128:993-997.
24. Henriksen JM. Effect of inhalation of corticosteroids on exercise induced asthma: Randomized double blind crossover study of budesonide in asthmatic children. Br Med J. 1985; 291: 248-249.
25. Waalkens HJ, Van Essen-Zandvliet EEM, Gerritsen J, Duiverman EJ, Kerrebijn KF, Knol K, Dutch CNSLD Study Group. The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Eur Respir J. 1993; 6:652-656.
26. Jenkins CR, Woolcock AJ. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: A comparative study. Thorax. 1988; 43:378-384.
27. Mattoli S, Rosati G, Mormile F, Ciappi G. The immediate and short-term effects of corticosteroids on cholinergic hyperreactivity and pulmonary function in subjects with well controlled asthma. J Allergy Clin Immunol. 1985; 76:214-222.
28. Israel RH, Poe RH, Wicks CM, Greenblatt DW, Kallay MC. The protective effect of methylprednisolone on carbachol induced bronchospasm. Am Rev Respir Dis. 1984; 130:1019-1022.
29. Bhagat RG, Grunstein MM. Effect of corticosteroids on bronchial responsiveness to methacholine in asthmatic children. Am Rev Respir Dis. 1985; 131:902-906.
30. Sotomayor H, Badier M, Vervloet D, Orehek J. Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids. Am Rev Respir Dis. 1984; 130:56-61.
31. Ramsdell JW, Berry CC, Clausen JL. The immediate effects of cortisol on pulmonary function in normals and asthmatics. J Allergy Clin Immunol. 1983; 72:69-74.
32. Ellul-Micallef R. The acute effects of corticosteroids in bronchial asthma. Eur J Respir Dis. 1982; 63(suppl 122):118-122.
33. Ellul-Micallef R, Hansson E, Johansson SA. Budesonide: A new corticosteroid in bronchial asthma. Eur J Respir Dis. 1980; 61: 167-171.
34. Szefler SJ. Glucocorticoid therapy for asthma: Clinical pharmacology. J Allergy Clin Immunol. 1991; 88:147-165.
35. Kelly HW, Murphy ES. Corticosteroids for acute severe asthma. DICP. 1991; 25:72-79.
36. Rieder MJ, Koren G. The pharmacotherapy of acute and chronic asthma. In: Nussbaum E, ed. Pediatric Intensive Care. Mount Kisco, NY: Futura Publishing, 1989:887-913.
37. Nassif E, Weinberger M, Sherman B, Brown K. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol. 1987, 80:518-529.
38. Zora JA, Zimmerman D, Carey TL, O'Connell EJ, Yunginger JW. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol. 1986; 76:9-13.
39. Dolan LM, Kesarwala HH, Holroyde JC, Fischer TJ. Short-term, high-dose systemic steroids in children with asthma: The effect on hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol. 1987; 80:81-87.
40. Pedersen S. Safety aspects of corticosteroids in children. Eur Respir Rev. 1994; 4:33-43.
41. König P. The risks and benefits of inhaled corticosteroids. Eur Respir Rev. 1993; 3:501-510.
42. Barnes PJ, Pedersen S Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis. 1993; 148:S1-S26.
43. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. 1995; 332:868-875.
44. Russell G. Inhaled corticosteroid therapy in children: An assessment of the potential for side effects. Thorax. 1994; 49: 1185-1188.
45. Tinkelman DG, Reed CE, Nelson HS. Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics. 1993; 92:64-77.
46. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med. 1995; 151:1715-1719.
47. Canny GJ, Levison H. Aerosols. Therapeutic use and delivery in childhood asthma. Ann Allergy. 1988; 60:11-20.
48. Pedersen S, Mortensen S. Use of different inhalation devices in children. Lung. 1990; 168(suppl):653-657.
49. Salzman GA, Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol. 1988; 81:424-428.
50. Prahl P, Jensen T. Decreased adreno-cortical suppression utilizing the Nebuhaler for inhalation of steroid aerosols. Clin Allergy. 1987; 17:393-398.
51. Pedersen S. How to use a rotahaler. Arch Dis Child. 1986; 61:11-14.
52. Thorsson L, Edsbacker S, Conradson T-B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MD1. Eur Respir J. 1994; 7:1839-1844.
53. Agertorft L, Pedersen S. Importance of the inhalation device on the effect of budesonide. Arch Dis Child. 1993; 69:130-133.
54. Grove A, McFarlane LC, McPhate G, Jackson CM, Lipworth BJ. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol. 1994; 38:527-532.
55. Selroos O, Halme M. Effect of volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax. 1991; 46:891-894.
56. Leflein J, Brown E, Hill M, Kelly HW, Loffert DT, Nelson HS, Szefler SJ. Delivery of glucocorticoids by jet nebulization: Aerosol characteristics and output. J Allergy Clin Immunol. 1995; 95:944-949.
57. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulisers. Arch Dis Child. 1992; 67:586-591.
58. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years treatment with inhaled steroids. Eur Respir J. 1988; 1:883-889.
59. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson S-A. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: A quantitative light and electron microscopic study. Am Rev Respir Dis. 1992; 145:890-899.
60. Burke C, Power CK, Norris A, Condez A, Schmekel B, Poulter LW. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J. 1992; 5:73-79.
61. Adelroth E, Rosenhall L, Johansson S-A, Linden M, Venge P Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. Am Rev Respir Dis. 1990; 142:91-99.
62. Rayan G, Latimer KM, Juniper EF, Roberts RS, Hargreave FE. Effect of beclomethasone diproprionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma. J Allergy Clin Immunol. 1985; 75:25-30
63. Kraan J, Koeter GH, van der Mark TW, Sluiter HJ, de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985; 76:628-636.
64. Dutoit JI, Salome CM, Woolcock AJ Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not. Am Rev Respir Dis. 1987; 136: 1174-1178.
65. Svendsen UG, Frolund L, Madsen F, Nielsen NH, Holstein-Rathlou NH, Weeke B. A comparison of the effects of sodium cromoglycate and beclomethasone dipropionate on pulmonary function and bronchial hyperreactivity in subjects with asthma. J Allergy Clin Immunol. 1987; 80:68-74.
66. Kraan J, Koeter GH, van der Mark TW, Boorsma M, Kukler J, Sluiter HJ, de Vries K. Dosage and time effect of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis. 1988; 137:44-48
67. Molema J, van Herwaarden CLA, Folgering HTM. Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma. Eur Respir J. 1989; 2:308-316.
68. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH. O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non steroid-dependent asthmatics. Am Rev Respir Dis. 1990; 142:832-836.
69. Bel EH, Timmers MC, Hermans JO, Dijkman JH, Sterk PJ. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in non-atopic asthmatic subjects. Am Rev Respir Dis. 1990; 141: 21-28.
70. Juniper EF, Kline PA, Vanzieleghem MA, Hargreave FE. Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements of airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol. 1991; 87:483-489.
71. Bel EH, Timmers MC, Zwinderman AH, Dijkman JH, Sterk PJ. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis. 1991; 143:109-113.
72. Vathenen AS. Knox AJ, Wismewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis. 1991; 143:1317-1321.
73. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, Sovijärvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA. Comparison of a beta2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991; 325:388-392.
74. Groot CAR, Lammers J-WJ, Molema J, Festen J, van Herwaarden CLA. Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsiveness to histamine and distilled water. Eur Respir J. 1992; 5:1075-1082.
75. Kerrebijn KF, van Essen-Zandvliet EEM, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987; 79:653-659.
76. Kraemer R, Sennhauser F, Reinhardt M. Effects of regular inhalation of beclomethasone dipropionate and sodium cromoglycatc on bronchial hyperreactivity in asthmatic children. Acta Paediatr Scand. 1987; 76:119-123.
77. de Baets FM, Goetyn M, Kerrebijn KF. The effect of two months of treatment with inhaled budesonide on bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children. Am Rev Respir Dis. 1990; 142:581-586.
78. Waalkens HJ, Gerritsen J, Koeter GH, Krouwels FH, van Aalderen WMC, Knol K. Budesonide and terbutaline or terbutaline alone in children with mild asthma: Effects on bronchial hyperresponsiveness and diurnal variation in peak flow. Thorax. 1991; 46:499-503.
79. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF, Dutch Chronic Non-Specific Lung Disease Study Group. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2 agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis. 1992; 146:547-554.
80. Katsunuma T, Hashimoto K, Akimoto K, Ebisawa M, Iikura Y. Effect of inhaled beclomethasone dipropionate on bronchial responsiveness in patients with asthma. Ann Allergy. 1993; 70: 165-170.
81. Waalkens HJ, van Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, Knol K, Kerrebijn KF, Dutch Chronic Non-Specific Lung Disease Study Group. Cessation of long-term treatment with inhaled corticosteroids (budesonide) in children with asthma results in deterioration. Am Rev Respir Dis. 1993; 148:1252-1257.
82. Vathenen AS, Knox AJ, Wisniernski A, Tattersfield AE. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise and eucapnic dry air hyperventilation in patients with asthma. Thorax. 1991; 46:811-816.
83. Fuller RW, Choudry NB, Eriksson G. Actions of budesonide on asthmatic airway hyperresponsiveness. Effects on directly and indirectly acting bronchodilators. Chest. 1991; 100:670-674.
84. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T. Selroos O, Sovijarvi A, Stenius-Aarniala R, Svahn T, Tammivaara R, Laitinen LA. Effects of reducing or discontinuating inhaled budesonide in patients with mild asthma. N Engl J Med. 1994; 331:700-705.
85. Asthma: A follow-up statement from an International Paediatric Asthma Consensus Group. Arch Dis Child. 1992; 67:240-248.
86. International Asthma Management Project. International consensus report on the diagnosis and management of asthma. Clin Exp Allergy. 1992; 22(suppl 1):1-72.
87. Guidelines on the management of asthma. Thorax. 1993; 48(suppl):S1-S24.
88. Reed CE. Aerosol steroids as primary treatment of mild asthma. N Engl J Med. 1991; 325:425-426.
89. Agertorft L, Pedersen S Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary functions in asthmatic children. Respir Med. 1994; 88:373-381.
90. Check WA, Kaliner MA. Pharmacology and pharmacokinetics of topical corticosteroids derivatives used for asthma therapy. Am Rev Respir Dis. 1990; 141(suppl 2):S44-S51.
91. Springer C, Avital A, Maayan CH, Rosier A, Godfrey S. Comparison of budesonide and beclomethasone dipropionate for treatment of asthma. Arch Dis Child. 1987; 62:815-819.
92. MacKenzie CA, Weinberg EG, Tabachnik E, Taylor M, Havnen J, Crescenzi K. A placebo controlled trial of fluticasone propionate in asthmatic children. Eur J Pediatr. 1993; 152:856-860.
93. Gustafsson P, Tsanakas J, Gold M, Primahak R, Radford M, Gillies E. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma. Arch Dis Child. 1993; 69:206-211.
94. Toogood JH. An appraisal of the influence of dose frequency on the antiasthmatic activity of inhaled corticosteroids. Ann Allergy. 1985; 55:2-1.
95. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankani JP, Follows RM, Tollemar U, Richardson PD. Pulmicort Turbuhaler once daily as initial prophylactic therapy for asthma. Respir Med. 1994; 88:293-299.
96. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma: A dose-response study. J Allergy Clin Immunol. 1995; 95:29-33.
97. Toogood JH. High dose inhaled steroid therapy for asthma. J Allergy Clin Immunol. 1989; 83:528-536.
98. Milner AD. Inhaled topical corticosteroids in the first two years of life. Eur Respir Rev. 1993; 3:329-332.
99. Storr J, Lenney CA, Lenney W. Nebulised beclomethasone dipropionate in preschool asthma. Arch Dis Child. 1986; 61: 270-273.
100. Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of severe steroid dependent preschool asthma with nebulized budesonide suspension. Arch Dis Child. 1993; 68:356-359.
101. de Benedictis FM, Martinati L, Solinas LF, Tuteri G, Boner AL. Nebulized flunisolide in infants and young children with asthma. Pediatr Pulmonol. 1996; 21:310-315.
102. Gleeson JGA, Price JF. Controlled trial of budesonide given by the Nebuhaler in preschool children with asthma. Br Med J 1988; 297:163-166.
103. Bisgaard H, Munck SL, Nielsen JP, Petersen JP, Ohlsson SV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990; 336.649-651.
104. Noble Y, Ruggins NR, Everard ML, Milner AD. Inhaled budesonide via a modified nebuhaler for chronic wheezing in infants. Arch Dis Child. 1992; 67:285-288.
105. Connett GJ, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child. 1993; 69:351-355.
106. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child. 1994; 72:317-320.
107. Moss RB. Alternative pharmacotherapies for steroid-dependent asthma. Chest. 1995; 107:817-825.
108. Weinberger M. Corticosteroids for exacerbations of asthma Current status of the controversy. Pediatrics. 1988; 81:726-729.
109. Littenberg B, Gluck E. A controlled trial of methylprednisolone in the emergency department of acute asthma. N Engl J Med. 1986; 314:150-152.
110. Storr J, Barrell E, Barry W, Lenney W Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1987; 1:879-882.
111. Tal A, Levy N, Bearman JE. Methylprednisolone therapy for acute asthma in infants and toddlers: A controlled clinical trial. Pediatrics. 1990; 86:350-356.
112. Connett GJ, Warde C, Wooler E, Lenney W. Prednisolone and salbutamol in the hospital treatment of acute asthma. Arch Dis Child. 1994; 70:170-173.
113. Scarfone R, Fuchs S, Nager A, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. 1993; 92:513-518.
114. Shapiro GG, Furukawa CT, Pierson WE, Gardinier R, Bierman W. Double-blind evaluation of methylprednisolone versus placebo for acute asthma episodes. Pediatrics. 1983; 71:510-514.
115. Horowitz L, Zafrir O, Gilboa S, Berger I, Wolach B. Acute asthma. Single dose oral steroids in paediatric community clinics. Eur J Pediatr. 1994; 153:526-530.
116. Younger RE, Gerber PS, Harrod HG, Cohen RM, Crawford LV. Intravenous methylprednisolone efficacy in status asthmaticus of childhood. Pediatrics. 1987; 80:225-230.
117. Gleeson JGA, Loftus BG, Price JF. Placebo controlled trial of systemic Corticosteroids in acute childhood asthma. Acta Paediatr Scand. 1990; 79:1052-1058.
118. Engel T, Heinig JH. Glucocotticoid therapy in acute severe asthma - a critical review. Eur Respir J 1991; 4:881-889.
119. Barnes NC. Effects of Corticosteroids in acute severe asthma. Thorax. 1992; 47:582-583.
120. Editorial. Lancet. 1992; 340:1384-1385.
121. Harrison BDW, Stokes TC, Hart GJ, Vaughan DA, Ali NJ, Robinson AA. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet. 1986; 1:181-184.
122. Ratto D, Alfaro C, Sipsey J, Glosvky MM, Sharma OP. Are intravenous Corticosteroids required in status asthmaticus? JAMA. 1988; 260:527-529.
123. Hoffman J, Fiel SB. Oral versus repository corticosteroid therapy in acute asthma. Chest 1988; 93:11-13.
124. Greos LS, Vichyanond P, Bloedow DC, Irvin CG, Larsen GL, Szefler SJ, Hill MR. Methylprednisolone achieves greater concentrations in the lung than prednisolone. Am Rev Respir Dis. 1991; 144:586-592.
125. Harfi H, Hanissian AS, Crawford LV. Treatment of status asthmaticus in children with high doses and conventional doses of methylprednisolone. Pediatrics. 1978; 61:829-831.
126. Cropp GJA. The treatment of severe asthma in childhood. Pediatr Pulmonol. 1995; suppl 11:49-50.
127. Desphande A, McKenzie SA. Short course of steroid in home treatment of children with acute asthma. Br Med J 1986; 293:169-171.
128. Harris JB, Weinberger MM, Nassif E, Smith G, Milavetz G, Stillerman A. Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incom-pletely responsive to bronchodilators. J Pediatr. 1987; 110:627-633.
129. Brunette MG, Lands L, Thibodeau LP. Childhood asthma: Prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. Pediatrics. 1988; 81:624-629.
130. Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child. 1993; 68:85-87.
131. Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child. 1990; 65:407-410.
132. Tunnessen W, Feinstein A. The steroid-croup controversy: An analytic review of methodologic problems. J Pediatr. 1980; 96:751-756.
133. Cherry J. The treatment of croup: Continued controversy due to failure of recognition of historic, ecologic, etiologic and clinical perspectives. J Pediatr. 1979; 94:352-354.
134. Novik A. Corticosteroid treatment of non diphtheric croup. Acta Otolaryngol. 1960; 158(suppl):20-23.
135. Martensson B, Nilson G, Torbjar J. The effect of corticosteroids in the treatment of pseudo-croup. Acta Otolaryngol. 1960; 158(suppl):62-71.
136. Eden A, Larkin VP. Corticosteroid treatment of croup. Pediatrics. 1964; 33:768-769.
137. Skowron PN, Turner JAP, McNaughton GA. The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Can Med Assoc J. 1966; 94:528-531.
138. Eden A, Kaufman A, Yu R. Corticosteroids and croup. JAMA. 1967; 200:403-404.
139. James J. Dexamethasone in croup: A controlled study. Am J Dis Child. 1969; 117:511-516.
140. Leipzig B, Oski FA. A prospective randomized study to determine the efficacy of steroids in the treatment of croup. J Pediatr 1969, 94:194-196.
141. Muhlendahl KE, Kahn D, Sporhl HL, Dressler F. Steroid treatment in pseudo-croup. Helv Paediatr Acta. 1982; 37:431-436.
142. Koren G, Frand M, Barzilay Z, MacLeod SM. Corticosteroid treatment of laryngotracheitis vs spasmodic croup in children. Am J Dis Child. 1983; 137:941-944.
143. Skolnik NS. Treatment of croup. A critical review. Am J Dis Child. 1989; 143:1045-1049.
144. Kairys SW, Olmstead EM, O'Connor GT. Steroid treatment of laryngotracheobronchitis: A meta-analysis of the evidence from randomized trials. Pediatrics. 1989; 83:683-693.
145. Kuusela AL, Vesikari T. A randomized double-blind placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Pediatr Scand. 1988; 77:99-104.
146. Super M, Cartelli MA, Brooks LY, Lembo RM, Koomar ML. A prospective randomized double-blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. J Pediatr. 1989; 115:323-329.
147. 146a. Geelhoed GC, Macdonald WBG. Oral dexamethasone in the treatment of croup. 0.15 mg/kg versus 0.6 mg/kg. Pediatr Pulmonol. 1995; 20:362-368.
148. Smith DS. Corticosteroids in croup: A chink in the ivory tower? J Pediatr. 1989; 115:256-257.
149. Tibballs J, Shann FA, Landau LI. Placebo-controlled trial of prednisolone in children intubated for croup. Lancet. 1992; 340: 745-748.
150. Husby S, Agertorft L, Mortensen S. Pedersen S. Treatment of croup with nebulized steroid (Budesonide): A double blind, placebo controlled study. Arch Dis Child. 1993; 68:352-355.
151. Klassen TP, Feldman ME, Watters LK, Sutcliff T, Rowe PC. Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med. 1994; 331:285-289.
152. Geelhoed GC, Macdonald WBG. Oral and inhaled steroids in croup: A randomized, placebo-controlled trial. Pediatr Pulmonol. 1995; 20:355-361.
153. Landau LI, Geelhoed GC. Aerosolized steroids for croup. N Engl J Med. 1994; 331:322-323.
154. Milner AD, Murray M. Acute bronchiolitis in infancy: Treatment and prognosis. Thorax. 1989; 44:1-5.
155. Sussman S, Grossman M, Magoffin R, Shielbe J. Dexamethasone in obstructive respiratory tract infection in children. A controlled study. Pediatrics. 1964; 34:851-855.
156. Dabouss IA, Tkachyk JS, Stamm SJ. A double-blind study of the effect of corticosteroids in the treatment of bronchiolitis. Pediatrics. 1966; 37:477-484.
157. Leer JA, Green JL, Heimlich EM, Hyde JS, Moffet HL, Young GA, Barron BA. Corticosteroid treatment in bronchiolitis: A controlled collaborative study in 297 infants and children. Am J Dis Child 1969; 117:495-503.
158. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics. 1983; 71:13-18.
159. Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol. 1990; 9:181-185.
160. Carlsen KH, Leegaard J, Larsen S, Orstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child. 1988; 63:1428-1433.
161. Panitch HB, Callahan CW Jr, Schidlow DV. Bronchiolitis in children. Clin Chest Med. 1993; 14 715-731.
162. Konstan MW, Berger M. Infection and inflammation in the lung in cystic fibrosis. In: Davis PB, ed. Cystic Fibrosis. New York: Marcel Dekker, 1993:219-276.
163. Lewiston NJ, Moss RB. Circulating immune complexes decrease during Corticosteroid therapy in cystic fibrosis. Pediatr Res. 1982; 4:354A.
164. Pantin CFA, Stead RJ, Hodson ME, Batten JC. Prednisolone in the treatment of airway obstruction in adults with cystic fibrosis. Thorax. 1986; 41:34-38.
165. Greally P, Hussain MJ, Vergani D, Price JF. Interleukin-Â soluble, interleukin-2 receptor and IgG concentrations in cystic fibrosis treated with prednisone. Arch Dis Child. 1994; 71:35-39.
166. Auerbach HS, Williams M, Kirkpatrick JA, Colten HR. Alternateday prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet. 1985; 2:686-688.
167. Donati MA, Haver K, Jerson W, Klein M, MacLaughlin FJ, Wohl MEB. Long term alternate day prednisone therapy in cystic fibrosis. Pediatr Pulmonol. 1990; suppl 5:277A.
168. Eigen H, Rosenstein B, FitzSimmons S, Schidlow DV, The Cystic Fibrosis Foundation Prednisone Trial Group. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. J Pediatr. 1995; 126:515-523.
169. Price JF, Greally P. Corticosteroid treatment in cystic fibrosis. Arch Dis Child. 1993; 68:719-721.
170. Schiotz PO, Jorgensen M, Winge Flensborg E, Faero O, Husby S, Hoiby N, Vidar Jacobsen S, Nielsen H, Svehag SE. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Acta Paediatr Scand. 1983; 72:283-287.
171. Bisgaard H, Nielsen KG, Skov M, Mosfeldt E, Bjerre B, Pedersen SS, Hoiby N, Koch C. Inhaled steroid treatment of CF patients with chronic Pseudomonas aeruginosa lung infection. Pediatr Pulmonol 1994; suppl 10:289A.
172. Caballero T, Ferrer A, Diaz-Pena JM, Garcia-Ara C, Pascual C, Martin-Esteban M. Childhood allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1995; 95:1044-1047.
173. Greenberger PA, Patterson R. Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy. 1986; 56:444-448.
174. Hilton AM, Chatterjie M. Bronchopulmonary aspergillosis: Treatment with beclomethasone dipropionate. Postgrad Med J. 1975; 51(suppl 4):98-103.
175. Report of the Research Committee of the British Thoracic Association. Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Br J Dis Chest. 1979; 73:349-356.
176. Heinig JH, Weeke ER, Groth S, Schwartz B. High dose local steroids in bronchopulmonary aspergillosis. Allergy. 1988; 43: 24-31.
177. Imbeault B, Cornier Y. Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis. Chest. 1993; 103:1614-1617.
178. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 1994; 149:1359-1374.
179. Inselman LS. Tuberculosis. In: Loughlin GM, Eigen H, eds. Respiratory Disease in Children. Diagnosis and Management. Baltimore, Williams & Wilkins, 1994:373-382.
180. Fan LL, Langston C. Chronic interstitial lung disease in children. Pediatr Pulmonol. 1993; 16:184-196.
181. Bokulik RE, Human BC. Interstitial lung disease in children. Pediatr Clin North Am. 1994; 41:543-567.
182. Brugman SN, Wilson H, Fan LL. Interstitial lung disease. In: Loughlin GM, Eigen H, eds. Respiratory Disease in Children. Diagnosis and Management. Baltimore: Williams & Wilkins, 1994:395-410.
183. Hilman BC. Interstitial lung disease in children. In: Human BC, ed. Pediatric Respiratory Disease: Diagnosis and Treatment. Philadelphia: WB Saunders, 1993:353-357.
184. Steinkamp G, Muller KM, Schirg E, VonderHardt A. Fibrosing alveolitis in childhood. A long-term follow-up. Acta Paediatr Scand 1990; 79:823-831.
185. Stillwell PC, Norris DG, O'Connell EJ, Rosenow EC, Weiland LH, Harrison EG. Desquamative interstitial pneumonitis in children. Chest. 1980; 77:165-171.
186. Wigger HJ, Berdon WE, Ores CN. Fatal desquamative interstitial pneumonia in an infant. Arch Pathol Lab Med. 1977; 101: 129-132.
187. Tal A, Maor E, Bar-Ziv J, Gorodischer R. Fatal desquamative interstitial pneumonia in three infant siblings. J Pediatr. 1984; 104:873-876.
188. Ackerman VL. Bronchopulmonary dysplasia. In: Loughlin GM, Eigen H, eds. Respiratory Disease in Children. Diagnosis and Management. Baltimore: Williams & Wilkins, 1994:383-394.
189. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am. 1994; 41:277-315.
190. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol. 1995; 19:371-378.
191. Ariagno RL. Use of steroids. In: Merrit TA, Northway WH, Boynton BR, eds. Bronchopulmonary Dysplasia. Boston: Blackwell Scientific, 1988:375-402.
192. Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child. 1993; 68:330-336.
193. Mammel MC, Green TP, Johnson DE, Thompson TR. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet. 1983; 1:1356-1358.
194. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent preterm infants with bronchopulmonary dysplasia. Pediatrics. 1985; 75:106-111.
195. Cummings JJ, D'Eugenio DB. Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989; 320:1505-1510.
196. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ. Dexamethasone therapy for chronic lung disease in ventilator dependent infants: A controlled trial. J Pediatr. 1989; 115:979-983.
197. Noble-Jamieson CM, Regev R, Silverman M. Dexamethasone in neonatal chronic lung disease: Pulmonary effects and intracranial complications. Eur J Pediatr. 1989; 148:365-367.
198. Kazzi NY, Brans YW, Poland RL. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics. 1990; 86: 722-727.
199. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double blind controlled study. J Pediatr. 1990; 117:273-282.
200. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: An international placebocontrolled trial. Pediatrics. 1991; 88:421-427.
201. Ohlsson A, Calvert S, Hosking M, Shennan A. Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatr. 1992; 81:751-756.
202. Kari MA, Heinonen K, Ikonen RS, Koivisto M, Raivio KO. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child. 1993; 68:566-569.
203. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res. 1994; 36:122-128.
204. Gerdes JS, Harris MC, Polin RA. Effects of dexamethasone and indomethacin on elastase, A1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr. 1988; 113:727-731.
205. Yoder MC, Chua R, Tepper R. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis. 1991; 143:1044-1048.
206. Watts C, Bruce M. Effect of dexamethasone therapy on fibronectin and albumin levels of lung secretions in infants with bronchopulmonary dysplasia. J Pediatr. 1992; 121:597-607.
207. Murch SH, Mac Donald TT, Wood CBS, Costeloe KL. Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 1992; 47:44-47.
208. Brozanski BS, Jones GJ, Gilmour CH, Balsan MJ. Vazquez RL, Israel BA, Newman B, Mimouni FB, Guthrie RD. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr. 1995; 126:769-776.
209. Frank L. Use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: A cautionary note. Pediatrics. 1991; 88:413-416.
210. Knoppert D, Mackanjee H. Current strategies in the management of bronchopulmonary dysplasia: The role of steroids. Neonat Netw. 1994; 13:53-60.
211. Dunn M, Magnani L, Belaiche M. Inhaled corticosteroids in severe bronchopulmonary dysplasia. Pediatr Res. 1989; 25:213 A.
212. Pappagallo M, Blondheim O, Bhutani V, Abbasi S. Effect of inhaled dexamethasone in ventilator dependent preterm infants. Pediatr Res. 1990; 27:1298A.
213. Pappagallo M, Bhutani V, Abbasi S. Nebulized steroid trial in ventilator-dependent preterm infants. Pediatr Res. 1991; 29:327A.
214. Pokriefka E, Mehdizadeh B, Rabbani A. Inhaled flunisolide in bronchopulmonary dysplasia. Pediatr Res. 1993; 33:341A.
215. König P, Shatley M, Levine C, Mawhinney TP. Clinical observations of nebulized flunisolide in infants and young children with asthma and bronchopulmonary dysplasia. Pediatr Pulmonol. 1992; 13:209-214.
216. Cloutier MM. Nebulized steroid therapy in bronchopulmonary dysplasia. Pediatr Pulmonol. 1993; 15:111-116.
217. Gal P, Diaz PR, Ransom JL, Carlos RQ, Thorson DW. Beclomethasone for treating premature infants with bronchopulmonary dysplasia: Guidelines for patient selection. J Pediatr. 1993; 123: 490-491.
218. La Force WR, Brudno DS. Controlled trial of beclomethasone dipropionate by nebulization in oxygen and ventilator dependent infants. J Pediatr. 1993; 122:285-288.
219. Avent ML, Gal P, Ransom JL. The role of inhaled steroids in the treatment of bronchopulmonary dysplasia. Neonat Netw. 1994; 13:63-69.
220. Calderwood H, Modell J, Ruiz B. The ineffectiveness of steroid therapy for treatment of fresh-water near-drowning. Anesthesiology. 1975; 43:642-649.
221. Moglan JA, Chan CK. Inhalation injury - an increasing problem. Surgery. 1978; 188:34-37.
222. Brown J, Burke B, Dajani AS. Experimental kerosene pneumonia: Evaluation of some therapeutical regimens. J Pediatr. 1974; 84: 396-401.
223. Steele R, Conkin R, Mark H. Corticosteroids and antibiotics for the treatment of fulminant hydrocarbon aspiration. JAMA. 1972; 219:1434-1437.
224. Wolfsdorf J, Kunding H. Dexamethasone in the management of kerosene pneumonia. Pediatrics. 1974; 53:86-90.
225. Kollfef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med. 1995, 332:27-35.
226. Ferrara TB, Georgieff MK, Ebert J. Fisher JB. Routine use of dexamethasone for the prevention of postextubation. J Perinatol. 1990; 9:287-290.
227. Tellez DW, Galvis AG, Storgion SA, Amer HN, Hoseyni M, Deakers TW. Dexamethasone in the prevention of postextubation stridor in children. J Pediatr. 1991; 118:289-294.
228. Couser RJ, Ferrara B, Falde B, Johnson K, Schilling C, Hoekstra RE. Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema. J Pediatr. 1992; 121:591-596.
229. Koka BV, Jeon ID, Andre JM, Mackay I, Smith RM. Postintubation croup in children. Anesth Analg. 1977; 56:501-505.
230. Bowman CM. Pulmonary hemosiderosis. In: Loughlin GM, Eigen H, eds. Respiratory Disease in Children. Diagnosis and Management. Baltimore: Williams & Wilkins, 1994:417-420.
231. Bye MR. Human immunodeficiency virus infections and the respiratory system in children. Pediatr Pulmonol. 1995; 19:231-242.
232. National Institutes of Health - University of California. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990; 323:1500-1504.
233. Sleasman JW, Hemenway C, Klein AS. Barrett DJ. Corticoste-roids improve survival of children with AIDS and Pneumocystis carinii pneumonia. Am J Dis Child. 1993; 147:30-34.
234. Bye MR, Cairns-Bazarian AM, Ewig YM. Markedly reduced mortality associated with corticosteroid therapy of Pneumocystis carinii pneumonia in children with AIDS. Arch Pediatr Adolesc Med. 1994; 148:638-641.
235. McLaughlin GE, Virdee SS, Schleien CL, Holzman BH, Scott GB. Effect of corticosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii-related respiratory failure. J Pediatr. 1995; 126:821-824.